Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 9
2012 3
2013 8
2014 3
2015 2
2016 2
2018 2
2019 2
2020 1
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Fluoroquinolone prophylaxis: a word of caution.
Lingaratnam S, Thursky KA, Slavin MA. Lingaratnam S, et al. Leuk Lymphoma. 2011 Jan;52(1):5-6. doi: 10.3109/10428194.2010.527408. Epub 2010 Nov 11. Leuk Lymphoma. 2011. PMID: 21067448 No abstract available.
Rituximab for the treatment of follicular lymphoma.
Cheah CY, Lingaratnam S, Seymour JF. Cheah CY, et al. Among authors: lingaratnam s. Future Oncol. 2013 Sep;9(9):1283-98. doi: 10.2217/fon.13.134. Future Oncol. 2013. PMID: 23980675
Epidemiology of invasive fungal disease in lymphoproliferative disorders.
Teng JC, Slavin MA, Teh BW, Lingaratnam SM, Ananda-Rajah MR, Worth LJ, Seymour JF, Thursky KA. Teng JC, et al. Among authors: lingaratnam sm. Haematologica. 2015 Nov;100(11):e462-6. doi: 10.3324/haematol.2015.126698. Epub 2015 Jul 23. Haematologica. 2015. PMID: 26206797 Free PMC article. No abstract available.
Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
Glewis S, Krishnasamy M, Lingaratnam S, Harris S, Underhill C, Georgiou C, Warren M, Campbell R, IJzerman M, Fagery M, Campbell I, Martin JH, Tie J, Alexander M, Michael M. Glewis S, et al. Among authors: lingaratnam s. Clin Transl Sci. 2023 Dec;16(12):2700-2708. doi: 10.1111/cts.13664. Epub 2023 Oct 31. Clin Transl Sci. 2023. PMID: 37877594 Free PMC article.
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial.
Glewis S, Alexander M, Lingaratnam S, Lee B, Campbell I, Krishnasamy M, IJzerman M, Fagery M, Harris S, Georgiou C, Underhill C, Warren M, Campbell R, Martin J, Tie J, Michael M. Glewis S, et al. Among authors: lingaratnam s. Acta Oncol. 2022 Sep;61(9):1136-1139. doi: 10.1080/0284186X.2022.2109423. Epub 2022 Aug 16. Acta Oncol. 2022. PMID: 35972781 No abstract available.
Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis.
Alexander M, Jachno K, Phillips KA, Seymour JF, Slavin MA, Cheung A, Shen V, Maarouf D, Wolfe R, Lingaratnam S. Alexander M, et al. Among authors: lingaratnam s. J Oncol Pharm Pract. 2023 Jun 16:10781552231180875. doi: 10.1177/10781552231180875. Online ahead of print. J Oncol Pharm Pract. 2023. PMID: 37322897
Thromboprophylaxis among Australasian colorectal surgeons.
Smart P, Burbury K, Lingaratnam S, Lynch AC, Mackay J, Heriot A. Smart P, et al. Among authors: lingaratnam s. ANZ J Surg. 2013 Sep;83(9):646-50. doi: 10.1111/j.1445-2197.2012.06245.x. Epub 2012 Sep 17. ANZ J Surg. 2013. PMID: 22985453
A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosing.
Glewis S, Alexander M, Khabib MNH, Brennan A, Lazarakis S, Martin J, Tie J, Lingaratnam S, Michael M. Glewis S, et al. Among authors: lingaratnam s. Br J Cancer. 2022 Jul;127(1):126-136. doi: 10.1038/s41416-022-01779-6. Epub 2022 Mar 19. Br J Cancer. 2022. PMID: 35306539 Free PMC article.
A randomised controlled trial of clinical pharmacy intervention versus standard care to improve medication adherence in outpatients with head and neck cancer receiving radiotherapy.
Maleki S, Glewis S, Fua T, Liu C, Rischin D, Alexander M, Na L, Lingaratnam S. Maleki S, et al. Among authors: lingaratnam s. Support Care Cancer. 2022 May;30(5):4243-4253. doi: 10.1007/s00520-021-06779-5. Epub 2022 Jan 28. Support Care Cancer. 2022. PMID: 35091845 Clinical Trial.
32 results